A detailed history of Dgs Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Dgs Capital Management, LLC holds 42,003 shares of NVO stock, worth $3.57 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
42,003
Previous 42,384 0.9%
Holding current value
$3.57 Million
Previous $6.05 Million 17.33%
% of portfolio
1.41%
Previous 1.76%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 10, 2024

SELL
$119.07 - $145.42 $45,365 - $55,405
-381 Reduced 0.9%
42,003 $5 Million
Q2 2024

Dec 10, 2024

SELL
$122.71 - $146.91 $61,845 - $74,042
-504 Reduced 1.18%
42,384 $6.05 Million
Q1 2024

Apr 15, 2024

BUY
$102.11 - $135.92 $117,528 - $156,443
1,151 Added 2.76%
42,888 $5.51 Million
Q4 2023

Jan 30, 2024

SELL
$87.78 - $105.45 $51,087 - $61,371
-582 Reduced 1.38%
41,737 $4.32 Million
Q3 2023

Jan 30, 2024

BUY
$90.94 - $199.54 $1.94 Million - $4.27 Million
21,382 Added 102.13%
42,319 $3.85 Million
Q2 2023

Jan 30, 2024

SELL
$155.98 - $172.65 $8,734 - $9,668
-56 Reduced 0.27%
20,937 $3.39 Million
Q1 2023

Jun 16, 2023

BUY
$132.34 - $159.14 $794 - $954
6 Added 0.03%
20,993 $3.34 Million
Q4 2022

Feb 21, 2023

SELL
$102.55 - $135.33 $30,662 - $40,463
-299 Reduced 1.4%
20,987 $2.84 Million
Q3 2022

Feb 21, 2023

BUY
$95.28 - $116.93 $113,287 - $139,029
1,189 Added 5.92%
21,286 $2.12 Million
Q2 2022

Jul 28, 2022

SELL
$103.24 - $121.81 $34,688 - $40,928
-336 Reduced 1.64%
20,097 $2.24 Million
Q1 2022

May 05, 2022

BUY
$93.1 - $112.54 $244,015 - $294,967
2,621 Added 14.71%
20,433 $2.27 Million
Q4 2021

Jan 28, 2022

BUY
$95.88 - $117.08 $1.71 Million - $2.09 Million
17,812 New
17,812 $2 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Dgs Capital Management, LLC Portfolio

Follow Dgs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dgs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dgs Capital Management, LLC with notifications on news.